Literature DB >> 26103121

Elevated neuronal α-synuclein promotes microglia activation after spinal cord ischemic/reperfused injury.

Hongfei Qiao1, Qiaojun Zhang, Haifeng Yuan, Yali Li, Dong Wang, Rui Wang, Xijing He.   

Abstract

The present study aimed to investigate the mechanism of injured neurons caused by ischemia/reperfusion in the induction of microglia activation. Spinal neurons were prepared and exposed to ischemic/reperfused conditions. The α-synuclein protein levels in these cells were analyzed by western blot, immunofluorescence, or enzyme-linked immunosorbent assay. Ischemia/reperfusion exposure led to elevated α-synuclein protein expression and release. Furthermore, when cocultured with injured neurons or supernatants from injured neurons, nitric oxide generation, H2O2 production, and tumor necrosis factor-α expression were promoted in microglia. Nevertheless, this effect was impeded by pretreatment of the α-synuclein antibody in the supernatants from injured neurons. Moreover, toll-like receptor 2 (TLR2) rather than TLR3 or TLR4 mediated microglia activation by α-synuclein. This process involved p38 MAPK and NF-κB activation, the inhibition of which resulted in reduced NADPH oxidase 2 (Nox2) in microglia. In conclusion, ischemia/reperfusion-injured neurons could express and release increased levels of α-synuclein and cause microglia activation through TLR2 both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26103121     DOI: 10.1097/WNR.0000000000000406

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  14 in total

Review 1.  Transient Receptor Potential Channels in Microglia: Roles in Physiology and Disease.

Authors:  Santiago Echeverry; María Juliana Rodriguez; Yolima P Torres
Journal:  Neurotox Res       Date:  2016-06-03       Impact factor: 3.911

2.  Effects of Alpha-Synuclein on Primary Spinal Cord Neurons Associated with Apoptosis and CNTF Expression.

Authors:  Guo-Ying Feng; Jia Liu; You-Cui Wang; Zhen-Yu Wang; Yue Hu; Qing-Jie Xia; Yang Xu; Fei-Fei Shang; Mei-Rong Chen; Fang Wang; Xue Zhou; Ting-Hua Wang
Journal:  Cell Mol Neurobiol       Date:  2016-08-31       Impact factor: 5.046

Review 3.  Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological Target.

Authors:  Natalie E Scholpa; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2017-09-21       Impact factor: 4.030

4.  Tat-p27 Ameliorates Neuronal Damage Reducing α-Synuclein and Inflammatory Responses in Motor Neurons After Spinal Cord Ischemia.

Authors:  Woosuk Kim; Hyun Jung Kwon; Hyo Young Jung; Kyu Ri Hahn; Seung Myung Moon; Yeo Sung Yoon; In Koo Hwang; Soo Young Choi; Dae Won Kim
Journal:  Neurochem Res       Date:  2021-08-17       Impact factor: 3.996

5.  The Role of AlphαSynuclein in Mouse Models of Acute, Inflammatory and Neuropathic Pain.

Authors:  Moritz Möller; Christine V Möser; Ulrike Weiß; Ellen Niederberger
Journal:  Cells       Date:  2022-06-19       Impact factor: 7.666

Review 6.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

7.  α-Synuclein activates innate immunity but suppresses interferon-γ expression in murine astrocytes.

Authors:  Jintang Wang; Zheng Chen; Jeremy D Walston; Peisong Gao; Maolong Gao; Sean X Leng
Journal:  Eur J Neurosci       Date:  2018-05-19       Impact factor: 3.386

Review 8.  Exploring Braak's Hypothesis of Parkinson's Disease.

Authors:  Carmen D Rietdijk; Paula Perez-Pardo; Johan Garssen; Richard J A van Wezel; Aletta D Kraneveld
Journal:  Front Neurol       Date:  2017-02-13       Impact factor: 4.003

Review 9.  NADPH oxidases in Parkinson's disease: a systematic review.

Authors:  Karim Belarbi; Elodie Cuvelier; Alain Destée; Bernard Gressier; Marie-Christine Chartier-Harlin
Journal:  Mol Neurodegener       Date:  2017-11-13       Impact factor: 14.195

10.  Ambroxol for the treatment of fibromyalgia: science or fiction?

Authors:  Kai-Uwe Kern; Myriam Schwickert
Journal:  J Pain Res       Date:  2017-08-16       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.